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Abstract
Background: A high prevalence of lifetime psychiatric disorders among help-seeking substance
abusers has been clearly established. However, the long-term course of psychiatric disorders and
mental distress among help-seeking substance abusers is still unclear. The aim of this research was
to examine the course of mental distress using a six-year follow-up study of treatment-seeking
substance-dependent patients, and to explore whether lifetime Axis I and II disorders measured at
admission predict the level of mental distress at follow-up, when age, sex, and substance-use
variables measured both at baseline and at follow-up are controlled for.    
Methods: A consecutive sample of substance dependent in- and outpatients (n = 287) from two
counties of Norway were assessed at baseline (T1) with the Composite International Diagnostic
Interview (Axis I), Millon's Clinical Multiaxial Inventory (Axis II), and the Hopkins Symptom
Checklist (HSCL-25 (mental distress)). At follow-up (T2), 48% (137/287 subjects, 29% women)
were assessed with the HSCL-25, the Alcohol Use Disorders Identification Test, and the Drug Use
Disorders Identification Test.    
Results: The stability of mental distress is a main finding and the level of mental distress remained
high after six years, but was significantly lower among abstainers at T2, especially among female
abstainers. Both the number of and specific lifetime Axis I disorders (social anxiety disorder,
generalized anxiety disorder, and somatization disorder), the number of and specific Axis II
disorders (anxious and impulsive personality disorders), and the severity of substance-use disorder
at the index admission were all independent predictors of a high level of mental distress at follow-
up, even when we controlled for age, sex, and substance use at follow-up.
Conclusion: These results underscore the importance of diagnosing and treating both substance-
use disorder and non-substance-use disorder Axis I and Axis II disorders in the same programme.
Background
A high prevalence of lifetime psychiatric disorders among
help-seeking substance abusers has been clearly estab-
lished [1-3]. Comorbidity is found to contribute to
readmission for both the substance use disorder (SUD)
and the mental disorder, and concerning treatment out-
come conflicting results have been reported (3) However,
the long-term course of psychiatric disorders and mental
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distress (symptoms of anxiety and depression) among
help-seeking substance abusers is still unclear. The litera-
ture is somewhat contradictory concerning the course of
mental distress in substance-abusing patients. A decrease
in mental distress over time has been reported in patients
dependent on opiates [4], cocaine [5,6], and alcohol [7-
11], as well as in mixed samples [12]. In contrast, other
studies have reported stability  in cocaine-dependent
patients [13], in alcohol-dependent patients [14,15], and
in mixed samples [16]. Some studies with more than one
follow-up have shown a decrease from baseline to the first
follow-up and then stability [17]. These contradictory
findings may be due to differences in sampling, the prev-
alence of sober patients, the duration of follow-up inter-
vals, and the methods used to measure mental distress.
Therefore, there is a clear need for prospective, long-term
follow-up studies of clinically representative samples that
are evaluated with reliable and valid methods at the index
admission to treatment.
Several studies found no association between the severity
of baseline substance use and later mental distress. This
was the case for patients dependent on alcohol [18],
cocaine [13], as well as abusers of amphetamines and
cocaine [19]. Other studies found a correlation between
the severity of substance dependence at baseline and psy-
chopathology at follow-up. This was observed by Carroll
et al. in cocaine abusers [5], and Rounsaville et al. [20] in
alcohol-dependent patients, but only among men. The
reasons for these contradictory findings may again be due
to differences in sampling, the method of measuring the
severity of substance dependence and mental distress, and
differences in the time between admission and follow-up.
Several factors have been studied as possible predictors of
levels of mental distress at follow-up: psychopathology,
substance use factors, and sociodemographic factors. A
number of studies have found an association between the
number of Axis I disorders and mental distress at follow-
up [20-24]. A recent review of mainly short-term follow-
up studies of substance-use disorder (SUD) patients
found that Axis II disorders were often associated with
poor psychiatric outcomes, such as suicidal behaviour,
anxiety, and depression [25]. There is a lack of long-term
outcome studies (> 5 years) focusing on the importance of
Axis I and II disorders for the level of mental distress in
SUD populations. It is also important to control for sub-
stance use both at index admission and at follow-up when
the impact of Axis I and II disorders on the course of men-
tal distress is explored.
Against this background, we have conducted a six-year
prospective follow-up study of a consecutive sample of
extensively assessed treatment-seeking substance-depend-
ent patients, from inpatient and outpatient facilities in
two counties in Norway. Our research questions were:
1. What is the level of, and change in mental distress six
years after admission in the total sample and in different
subgroups (sex, age at onset of SUD, main substance of
abuse, and Axis I and II disorders)?
2. Do lifetime Axis I and II disorders measured at admis-
sion predict the level of mental distress at follow-up,
when age, sex, and substance-use variables measured at
both baseline and follow-up are controlled for?
Methods
Sampling
A consecutive sample (n = 287) (70% men, mean age =
38.6 ± 11.3 years) of DSM-IV substance-dependent
patients (156 alcohol dependent and 131 poly-substance
dependent) from three outpatient (n = 157) and six inpa-
tient (n = 130) public facilities in two Norwegian counties
were recruited from September 1997 to November 1998.
In the six inpatient units, there were two therapeutic com-
munities, one shelter, one short-term unit (six weeks),
and two long-term units (between 3 and 18 months). Two
of the inpatient units were mainly for males, and one of
the units mainly for females. The therapeutic communi-
ties offered treatment for young drug addicts. The pro-
grams had abstinence and rehabilitation as their primary
goals and they offered both individual and group therapy.
Few of the programs assessed and treated psychiatric dis-
orders. The treatment in most programmes was not based
on a specific ideology or philosophy. The three outpa-
tients units offered mainly individual therapy, and the
main goals for treatment were abstinence and rehabilita-
tion.
The inclusion criterion for patients from the outpatient
facilities were at least three consultations, whereas in the
inpatient units, the patients had to stay at least for two
weeks to be included in the study. A total of 287 patients
from 690 consecutive subjects, who fulfilled the inclusion
criteria, were recruited to our index admission sample.
Thus, the participation rate was 42% (287/690). Those
who were not recruited either refused to participate, left
treatment prematurely, or most often, the clinicians did
not properly present the study proposal to the patient.
Those who were and those who were not recruited did not
differ significantly with regard to sociodemographic vari-
ables or substance-use variables, except for age. Our sam-
ple was somewhat older than the non-participants (38.6
years vs. 35.6 years, respectively, P < 0.001). Compared
with a national sample (n = 5000) drawn from the entire
Norwegian treatment-seeking population [26], our sam-
ple was somewhat older (23% vs. 36%, respectively, were
younger than 30 years, P < 0.001) and more frequentlyBMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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abused alcohol (63% vs. 50%, respectively, P < 0.001).
Patients in our sample were also more often married/
cohabiting (36% vs. 27%, P = 0.02). In general, our sam-
ple appeared somewhat skewed towards having fewer
young drug addicts compared with the national sample.
Further information about sampling, subjects and meth-
ods has been described more extensively in previous
papers from the index admission [2,27]. All patients gave
their written informed consent to assessment at admis-
sion and to be contacted at follow-up.
Six years later (mean time = 75 ± 5 months), 33 patients
(11%) had died and 21 deaths were substance related.
Two died from cancer, one from suicide, and two for
unknown reasons. The National Registry provided data
for the deceased patients. Death certificates (cause of
death) were obtained from the Cause of Death Registry
(Division for Health Statistics in Statistics Norway). At
baseline, the deceased patients (n = 33) were older (44.3
vs. 37.9 years, respectively, P = 0.002), more often alco-
holics (73% vs. 52%, respectively, P = 0.024), and more
likely to have a later onset of SUD (mean age at onset:
26.5 vs. 22.0 years, respectively, P = 0.024) than were the
254 surviving patients. In terms of lifetime Axis I disor-
ders, the deceased patients had fewer social anxiety disor-
ders (SADs) (23.3% vs. 48.6%, respectively, P = 0.009),
major depression (25.0% vs. 46.4%, respectively, P =
0.022), and a lower number of Axis I disorders (2.7 ± 2.2
vs. 3.7 ± 2.6, respectively, P = 0.035) than did survivors. In
terms of Axis II disorders, the deceased patients more
often had schizoid (46.4% vs. 19.6%, respectively, P =
0.001) or dependent personality disorders (35.7% vs.
18.5%, respectively, P = 0.033) than did survivors.
The six-year follow-up questionnaire was mailed to the
surviving individuals of the index admission sample (n =
254). Most of the patients were also contacted by tele-
phone. Subjects were paid 300 Norwegian kroner
(approximately 38 Euros) for completing the form.
Among the surviving patients (n = 254), 63% (n = 160,
29% of whom were women, mean age = 45.1 ± 11.2
years) returned the questionnaire and these constituted
the follow-up sample. Of the group that did not respond
at follow-up (n = 94), 14 patients actively refused to par-
ticipate, 23 were not located, and 57 subjects received the
assessment form twice (limit set by the Norwegian Data
Inspectorate), but did not reply to it. The participant rate
was similar to that for former patients from both outpa-
tient and inpatient facilities. Our follow-up sample (n =
160) did not differ significantly from those who did not
participate (n = 94) with regard to sociodemographic or
baseline variables: substance-use variables, Axis I and II
disorders, levels of mental distress (HSCL-25), inpatient
or outpatient status, and treatment history before admis-
sion.
At the six-year follow-up, not all members of the follow-
up sample had completed the HSCL-25 in an acceptable
way (21 subjects at baseline and two subjects at follow-
up), leaving us with 137 patients (86% of the follow-up
sample (137/160)) who had completed the HSCL-25
both at baseline and at follow-up. These 137 persons con-
stitute the sample of the present study. There were no sig-
nificant differences between these participants and the
non-participants (n = 117), including both the non-
responders (n = 94) and responders without HSCL-25 at
T1 or T2 (n = 23) with regard to sociodemographic, sub-
stance use, or mental health variables.
Evaluation at the index admission (baseline, T1)
The rating instrument used to assess sociodemographic
and treatment history was the Norwegian National Client
Assessment form.
Lifetime Axis I disorders were evaluated with a structured
interview, the Composite International Diagnostic Inter-
view (CIDI) [28]. Diagnosis of substance abuse, harmful
use, and dependence was made with the CIDI (based on
DSM-IV and ICD-10 criteria). ICD-10 diagnosis were used
for the non-substance Axis I disorders. The CIDI has
shown good feasibility in general populations and high
inter-rater reliability, and has been subjected to tests of
reliability and validity with satisfactory results [29]. This
interview was also used to identify age of onset of SUD,
i.e., the first year in which the person fulfilled the criteria
for a SUD diagnosis. An early age of onset of SUD was
defined as the onset of either substance abuse or sub-
stance dependence before the age of 18 years. The CIDI
was also used to classify the patient's main substance of
abuse as either alcohol dependence with no other drug
dependence or abuse, or as poly-substance dependence.
Among poly-substance dependent patients 85% used her-
oin and/or amphetamine as the primary substance of
abuse.
Mental distress was measured with the self-report instru-
ment, the Hopkins Symptom Checklist (HSCL-25) [30],
which is widely used in both population studies [31,32]
and patient populations [33]. The HSCL-25 consists of 25
items that predominantly measure anxiety and depression
symptoms over the course of the previous week. The mean
total sum score is called the General Symptom Index
(GSI). In our sample, 143 patients had fulfilled the HSCL-
25 form at admission. Four patients answered fewer than
16 questions and were therefore excluded from the analy-
ses, whereas eight patients who answered between 21 and
24 questions were included. Cronbach's alpha was 0.94.
There was a very high correlation between both the
number of lifetime Axis I and Axis II disorders and the
HSCL-25 score at baseline (r = 0.61, r = 0. 48, respec-
tively).BMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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Personality disorders were assessed using the self-report
instrument the Millon's Clinical Multiaxial Inventory
(MCMI-II) [34], a 175-item instrument to which patients
respond "true" or "false". This instrument measures 13
personality scales according to the DSM-III-R diagnostic
system. The cut-off value for "caseness" on the different
MCMI-II scales is a base rate score of 85 or more. This is a
more stringent criterion in assigning a suggested diagnosis
than is recommended by the MCMI manual, but was used
to ensure that the diagnostic criteria for any given person-
ality disorder was satisfied. Findings from several studies
of the psychometric properties of the MCMI-II have
reported acceptable test-retest reliability, and generally
acceptable levels of convergent and discriminant validity
of the scales [35].
The self-report instruments were completed in association
with the CIDI interview. Among inpatients, the CIDI
interview and the self-report instruments were conducted
four weeks after discontinuation of substance abuse at the
earliest. This demand of four weeks of sobriety was diffi-
cult to achieve in all outpatients. Therefore, we decided to
include those clients that failed to meet this criterion if
they were sober in the assessment situation.
Evaluation at the six-year follow-up (T2)
Because of a lack of resources, it was not possible to con-
duct personal interviews (CIDI) to evaluate psychiatric
diagnoses and SUD at follow-up. As an alternative, well-
established self-report instruments were used. The same
self-report instrument used at baseline, the HSCL-25, was
used at follow-up to measure mental distress. Cronbach's
alpha was 0.95.
Two self-report instruments measured substance use both
at the follow-up and during the preceding year: the Alco-
hol Use Disorders Identification Test (AUDIT) and the
Drug Use Disorders Identification Test (DUDIT). These
are instruments with good potential reliability and valid-
ity [36,37]. Both screening instruments are used to iden-
tify persons with a problematic use of substances during
the previous 12 months. The instruments are standard-
ized and based on selected criteria for substance abuse,
harmful use, and dependence, according to the ICD-10
and DSM-IV diagnostic systems. AUDIT was developed
from a six-country WHO collaborative project as a screen-
ing instrument for hazardous and harmful alcohol con-
sumption [38]. It is a 10-item questionnaire that includes
sections on alcohol consumption, alcohol dependence,
and alcohol-related problems. Responses to each ques-
tion are scored from 0 to 4, giving a maximum possible
score of 40. Screening levels for hazardous alcohol use are
≥ 8 points for men and ≥ 6 points for women. In our
study, reliability according to Cronbach's alpha was 0.94.
DUDIT was developed and tested in Sweden [37]. It is an
11-item self-report instrument intended for use in parallel
with AUDIT. Screening levels for drug-related problems
are ≥ 6 points for men and ≥ 2 for women out of a maxi-
mum of 44 points. Cronbach's alpha was 0.95.
Patients were classified into one of two groups, "abstain-
ers" or "relapsers", based on their AUDIT and DUDIT
scores. The "abstainers" (n = 41) consisted of persons with
no drug- or alcohol-related problems at follow-up or dur-
ing the immediately preceding 12 months (based on an
AUDIT score of < 8 points for men and < 6 points for
women and a DUDIT score of < 6 points for men and < 2
points for women). The "relapsers" (n = 96) consisted of
persons with drug- or alcohol-related problems during the
preceding year and at follow-up (based on an AUDIT
score of ≥ 8 for men and ≥ 6 for women, or a DUDIT score
of ≥ 6 for men and ≥ 2 for women).
Statistics
Quantitative measures were compared among groups
with analyses of variance (independent t-test, paired sam-
ples test, and one-way ANOVA) and with χ2 tests. Bivariate
correlations were measured using Pearson's product-
moment correlation coefficient. In table 1, 2, 3 we have
controlled for the level of HSCL-25 at T1 using linear
regression analyses, corresponding to ANCOVAs with
HSCL-25 at T2 as the dependent variable using the inde-
pendent variables investigated as factors and HSCL-25
score at T1 as a linear covariate. Finally, hierarchical mul-
tiple regression analysis was used, with the HSCL-25 score
at follow-up as the dependent variable. Four blocks of
independent variables were used to explore the predictive
value of each of the specific lifetime Axis I and II disorders
(one by one) and also the number of these disorders on
the level of mental distress at follow-up. Block one com-
prised the different individual Axis I disorders (one by
one) or, separately the number of Axis I disorders (0–11).
Block two comprised the different individual Axis II disor-
ders (one by one) or, separately the number of Axis II dis-
orders (0–9). When each of the different Axis I disorders
was tested, block two consisted of the number of Axis II
disorders, and when the different Axis II disorders were
tested, block one consisted of the number of Axis I disor-
ders. Block three was the baseline measures of sociodemo-
graphic variables (sex and age), the type of main
substance of abuse at the index admission, and age at SUD
onset; block four represented substance use at follow-up.
HSCL-25 scores at T1 and T2 showed a moderate test-
retest correlation (r = 0.43). In a separate analysis we
wanted to explore whether HSCL-25 scores at T1 would
affect the association between HSCL-25 scores at T2 and
the other putative predictors included in the regression
equation (table 4). In table 4 we reported only the first
four blocks due to the high correlation between Axis I dis-BMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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orders and HSCL-25 at T1 (r = 0.61). When we control for
HSCL-25 scores at T1 the effect of a given independent
variable on HSCL-25 at T2 will reflect differential change
in mental distress from T1 to T2. All analyses were con-
ducted using SPSS for Windows, version 11.0 (SPSS
2005).
Ethics
The study protocol was reviewed both at baseline and at
follow-up and approved by the Regional Committee for
Medical Research Ethics and by the Norwegian Data
Inspectorate.
Results
Level of and change in mental distress at the six-year 
follow-up
As shown in Table 1 there was a significant difference in
the level of mental distress at T2 between the age at onset
of SUD groups. The late-onset group had a lower level of
mental distress compared with that of the early-onset
group (1.90 ± 0.64 vs. 2.15 ± 0.59, respectively, P =
0.020). At T2, the "abstainers" had significantly lower
mental distress than that of the "relapsers" (1.61 ± 0.59 vs.
2.18 ± 0.56, respectively, P < 0.001).
On a group level, there was no significant difference in
mental distress between T1 (index admission) and T2
(follow-up) (2.08 ± 0.61 vs. 2.01 ± 0.63, respectively, P =
0.219). Concerning the course in different subgroups,
Table 1 shows that among women, but not among men,
there was a significant decrease in mental distress (2.19 ±
0.58 vs. 1.96 ± 0.58, P = 0.019). This was also the case
among patients with late-onset SUD, with mental distress
decreasing from 2.07 ± 0.63 to 1.90 ± 0.64 (P = 0.022). In
patients who were alcohol-dependent at admission, men-
tal distress was exactly the same at T1 and T2 (2.04 ± 0.63,
P = 0.930), whereas in patients who were poly-substance
dependent at admission, mental distress tended to
decrease but not significantly (from 2.13 ± 0.59 to 1.98 ±
0.63, P = 0.106).
Persons who were classified as "abstainers" at follow-up
showed a decrease in mental distress (1.94 ± 0.60 vs. 1.61
± 0.59, P = 0.002), whereas the "relapsers" reported a sta-
ble HSCL-25 level (2.14 ± 0.61 at T1 vs. 2.18 ± 0.56 at T2,
P = 0.514). Women "abstainers" displayed a significant
decrease in mental distress (from 2.14 ± 0.63 to 1.41 ±
0.37, P < 0.001), whereas men did not (from 1.85 ± 0.57
to 1.69 ± 0.66, P = 0.174) (not shown in Table 1). When
controlling for HSCL-25 at T1 in the analysis in table 1 age
Table 1: Mean score and standard deviation for HSCL-25 at baseline and follow-up, according to sociodemographic variables at 
baseline and substance-use variables at both at baseline and follow-up. Paired t-test and independent t-test.
T1 T2
Mean SD Mean SD Pa Pb
Total sample (n = 137) 2.08 0.61 2.01 0.63 0.219
Age
< 30 years (n = 28) 2.12 0.63 2.00 0.61 0.371 0.933
≥ 30 years (n = 109) 2.07 0.61 2.01 0.64 0.366
Sex
Male (n = 97) 2.03 0.62 2.03 0.65 0.996 0.513
Female (n = 40) 2.19 0.58 1.96 0.58 0.019
Education
Only primary school (n = 59) 2.20 0.62 2.11 0.61 0.317 0.150
More than primary school (n = 66) 2.00 0.60 1.95 0.65 0.543
Civil status
Not married/cohabiting (n = 77) 2.13 0.66 2.03 0.63 0.200 0.650
Married/cohabiting (n = 50) 2.02 0.56 1.98 0.65 0.589
Employment %
Yes (n = 44) 2.04 0.61 2.03 0.66 0.940 0.911
No (n = 83) 2.13 0.62 2.02 0.62 0.098
Main substance of abuse
Alcohol (n = 77) 2.04 0.63 2.04 0.63 0.930 0.578
Poly-substance abuse (n = 60) 2.13 0.59 1.98 0.63 0.106
Age at onset of substance use disorder
≥ 18 years (n = 76) 2.07 0.63 1.90 0.64 0.022 0.020
< 18 years (n = 61) 2.09 0.58 2.15 0.59 0.489
Use of substances at T2
"Abstainers" (n = 41) 1.94 0.60 1.61 0.59 0.002 < 0.001
"Relapsers" (n = 96) 2.14 0.61 2.18 0.56 0.514
aP value on paired t-test.
bP value on independent t-test T2BMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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Table 3: Mean score and standard deviation for HSCL-25 at 
baseline and follow-up, according to Axis II disorders. Paired t-
test and independent t-test.
T1 T2
Axis II disorders Mean SD Mean SD Pa Pb
Any Axis II 
disorder
Yes (98) 2.22 0.60 2.10 0.65 0.090 0.008
No (36) 1.76 0.51 1.79 0.52 0.733
Paranoid
Yes (n = 6) 2.40 0.56 2.55 0.31 0.638 0.035
No (n = 128) 2.08 0.61 1.99 0.63 0.139
Schizoid
Yes (n = 23) 2.45 0.65 2.25 0.54 0.224 0.049
No (n = 111) 2.02 0.58 1.97 0.64 0.397
Schizotyp
Yes (n = 17) 2.66 0.58 2.34 0.62 0.088 0.025
No (n = 117) 2.01 0.57 1.97 0.62 0.496
Antisocial
Yes (n = 43) 2.17 0.60 2.14 0.65 0.728 0.136
No (n = 91) 2.06 0.61 1.96 0.62 0.161
Borderline
Yes (n = 43) 2.45 0.58 2.26 0.61 0.110 0.002
No (n = 91) 1.92 0.55 1.90 0.62 0.699
Histrionic
Yes (n = 17) 2.14 0.61 2.04 0.83 0.533 0.849
No (n = 117) 2.09 0.61 2.01 0.60 0.238
Narcissistic
Yes (n = 19) 2.14 0.60 2.21 0.76 0.653 0.161
No (n = 115) 2.08 0.61 1.99 0.61 0.117
Avoidant
Yes (n = 52) 2.45 0.57 2.28 0.58 0.098 < 0.001
No (n = 82) 1.87 0.52 1.85 0.61 0.802
Dependent
Yes (n = 24) 2.43 0.62 2.19 0.69 0.051 0.129
No (n = 110) 2.02 0.58 1.98 0.62 0.529
Compulsive
Yes (n = 8) 2.34 0.86 2.19 0.77 0.544 0.420
No (n = 126) 2.08 0.59 2.01 0.63 0.226
Passive-aggressive
Yes (n = 54) 2.32 0.57 2.28 0.60 0.594 < 0.001
No (n = 80) 1.94 0.59 1.84 0.60 0.207
Self-defeating
Yes (n = 36) 2.59 0.59 2.33 0.62 0.045 < 0.001
No (n = 98) 1.91 0.51 1.90 0.60 0.886
Aggressive-sadistic
Yes (n = 33) 2.22 0.54 2.23 0.59 0.291 0.029
No (n = 101) 2.05 0.62 1.95 0.64 0.558
Number of Axis II 
disorders
0 (n = 36) 1.76 0.51 1.79 0.52 0.733 < 0.001c
1–3 (n = 47) 1.99 0.52 1.82 0.64 0.083
4 + (n = 51) 2.43 0.59 2.36 0.56 0.485
aP value on paired t-test.
bP value on independent t-test HSCL-25 T2
cOne-way ANOVA: number of Axis II disorders, df = 9, F = 4.0, P < 
0.001.
Table 2: Mean score and standard deviation for HSCL-25 at 
baseline and follow-up, according to Axis I disorders. Paired t-
test and independent t-test.
T1 T2
Mean SD Mean SD Pa Pb
Any Axis I 
disorder
Yes (123) 2.14 0.60 2.07 0.61 0.287 0.001
No (14) 1.60 0.42 1.49 0.53 0.445
Affective disorders
Yes (n = 85) 2.26 0.59 2.12 0.63 0.064 0.018
No (n = 50) 1.80 0.53 1.86 0.59 0.492
Major depression
Yes (n = 59) 2.27 0.61 2.15 0.61 0.177 0.44
No (n = 76) 1.95 0.58 1.93 0.63 0.802
Dysthymia
Yes (n = 50) 2.28 0.55 2.17 0.70 0.228 0.021
No (n = 83) 1.95 0.62 1.91 0.57 0.573
All anxiety 
disorders
Yes (n = 110) 2.18 0.61 2.10 0.63 0.267 < 0.001
No (n = 27) 1.69 0.43 1.64 0.49 0.583
Agoraphobiac
Yes (n = 61) 2.33 0.57 2.20 0.63 0.178 0.001
No (n = 74) 1.87 0.57 1.86 0.60 0.816
Social anxiety 
disorder
Yes (n = 65) 2.34 0.60 2.24 0.60 0.286 < 0.001
No (n = 69) 1.86 0.52 1.80 0.59 0.485
Simple phobias
Yes (n = 60) 2.29 0.69 2.08 0.65 0.034 0.268
No (n = 76) 1.92 0.48 1.96 0.61 0.508
Generalized 
anxiety disorder
Yes (n = 25) 2.32 0.62 2.27 0.67 0.701 0.022
No (n = 112) 2.03 0.60 1.95 0.61 0.243
Post-traumatic 
stress disorder
Yes (n = 29) 2.35 0.66 2.07 0.57 0.035 0.558
No (n = 107) 2.01 0.58 1.99 0.65 0.739
Somatization 
disorder
Yes (n = 39) 2.35 0.60 2.21 0.62 0.291 0.022
No (n = 97) 1.97 0.59 1.94 0.62 0.558
Number of Axis I 
disorders
0 (n = 14) 1.60 0.42 1.49 0.53 0.445 < 0.001d
1–3 (n = 58) 1.85 0.48 1.95 0.58 0.167
4 + (n = 65) 2.39 0.59 2.17 0.63 0.021
aP value on paired t-test.
bP value on independent t-test HSCL-25 T2.
cAgoraphobia with and without panic attack.
dOne-way ANOVA: number of Axis I disorders, df = 11, F = 3.5, P < 
0.001.BMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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at onset of substance use disorder (P = 0.013) and use of
substances at T2 (P = < 0.001) still remained significant.
The level of mental distress at T2 was significantly higher
for patients with any lifetime Axis I disorder (2.07 ± 0.61
vs. 1.49 ± 0.53, P = 0.001) compared with that of patients
with no Axis I disorder. This was the case also for nearly
all the specific Axis I disorders, except major depression,
simple phobias, and post-traumatic stress disorder
(PTSD). Patients with ≥ 4 lifetime Axis I disorders assessed
at baseline showed a significant decrease in HSCL-25
scores from baseline to follow up (2.39 ± 0.59 vs. 2.17 ±
0.63, P = 0.021), but the level was still high. Looking at
the change in mental distress in each single Axis I disorder
there was a significant decrease in patients only in two
diagnostic groups: simple phobias (2.29 ± 0.69 vs. 2.08 ±
0.65, P = 0.034) and PTSD (2.35 ± 0.66 vs. 2.07 ± 0.57, P
= 0.035).
The level of mental distress at T2 was significantly higher
for patients with any Axis II disorder (2.10 ± 0.65 vs. 1.79
± 0.52 in patients with no disorder, P = 0.008), and in
those with eight of the 13 personality disorders.
Patients with no personality disorder reported a stable
and relatively low level of mental distress (from 1.76 ±
0.51 to 1.79 ± 0.52, P = 0.733), whereas patients with ≥ 4
personality disorders reported a stable but high level of
mental distress (from 2.43 ± 0.59 to 2.36 ± 0.56, P =
0.485). Concerning each specific personality disorder
(Table 3), there was only a slight significant decrease in
mental distress in those patients with a self-defeating per-
sonality disorder (2.59 ± 0.59 vs. 2.33 ± 0.62, P = 0.045).
There was no significant decrease in mental distress in
patients who had been treated in the substance abuse field
(68%) or in the mental health care system (54%) between
T1 and T2. In all, 79% were treated either in one or two of
the treatment systems (not shown in Table 3).
In table 2 any Axis I disorder (P = 0.028), all anxiety dis-
order (P = 0.034) and social anxiety disorder (P = 0.017)
remained significant after controlling for baseline mental
distress. In table 3 only number of Axis II disorders (P =
0.008) and passive-aggressive disorder (P = 0.006)
remained significant.
To explore whether Axis I or II disorders predicted the
level of mental distress at follow-up, we used a hierarchi-
cal multiple regression analysis (Table 4), with the HSCL-
25 score at follow up as the dependent variable. The inde-
pendent variables were each of the different Axis I and II
disorders, one by one (1 = yes and 0 = no), or the number
of Axis I and II disorders, age, and sex (1 = male and 0 =
female), onset of SUD (1 = below 18 years and 0 = 18
years or older), main substance of abuse (1 = alcohol
dependence and 0 = poly-substance dependence) and use
of substances at T2 (1 = "relapser" and 0 = "abstainer").
The number of Axis I and II disorders, main substance of
abuse, and onset of SUD were significantly and independ-
ently related to a higher level of HSCL-25 at T2, whereas
sex and age were not (R2 = 0.24). These findings were, in
principle, the same when we controlled for "relapsers"/
"abstainers" at T2. The overall model was significant (F
[7,126] = 10.21, P < 0.001). When we looked at single
Axis I disorders, SAD, generalized anxiety disorder (GAD),
and somatization disorder were significantly and inde-
pendently related to higher mental distress at T2 control-
led for Axis II disorders. However, the standardized beta
(0.203) and adjusted R2  (0.327) values were slightly
higher for the number of Axis I disorders compared with
Table 4: Hierarchical multiple regression with the HSCL-25 
score at follow-up as the dependent variable and four blocks of 
independent variables. Standardized regression coefficients and 
adjusted R squares for each block (n = 134).
B SE Standardizert 
B
Adjusted 
R2
Block 1 0.13
Number of Axis I 
disorders
0.090 0.019 0.374***
Block 2 0.19
Number of Axis I 
disorders
0.063 0.021 0.260**
Number of Axis II 
disorders
0.068 0.021 0.282**
Block 3 0.24
Number of Axis I 
disorders
0.066 0.021 0. 274**
Number of Axis II 
disorders
0.066 0.021 0.273**
Sex (male = 1) 0.079 0.111 0.057
Age -0.004 0.005 -0.062
Main substance of 
abuse (alcohol = 1)
0.349 0.122 0.274**
Onset SUD 
(below 18 years = 1)
0.300 0.118 0.236*
Block 4 0.33
Number of Axis I 
disorders
0.049 0.020 0.203*
Number of Axis II 
disorders
0.068 0.019 0.280**
Sex (male = 1) 0.054 0.105 0.039
Age 0. 000 0.005 -0. 007
Main substance of 
abuse (alcohol = 1)
0.288 0.116 0.226*
Onset of SUD 
(below 18 years = 1)
0.238 0.113 0.187*
Use of substances at 
T2 ("relapser" = 1)
0.431 0.104 0.312***
*P < 0.05
**P < 0.01
***P < 0.001BMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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those for each of the specific disorders. Among these dis-
orders, SAD had the highest standardized beta (0.195)
and adjusted R2 (0.326) values compared with those for
GAD and somatization disorder.
In the same types of analyses, we found that having any
Axis II disorder (controlled for Axis I disorders) implied a
significantly higher level of mental distress at follow-up.
Concerning single personality disorders, five disorders
were significantly and independently related to a higher
level of mental distress at T2: borderline, passive-aggres-
sive, aggressive-sadistic, avoidant, and self-defeating.
However, as regarding Axis I disorders, the number of Axis
II disorders was a better predictor than each of the specific
Axis II disorders. When controlling for treatment (in all)
between T1 and T2 (measured by self-report), the only
change in predictors was that age of onset of SUD became
non-significant (90% of patients in the early-onset SUD
group had been treated between T1 and T2).
HSCL-25 at T1 was a significant predictor of HSCL-25
score at T2 (zero-order correlation corresponding to a
"stability coefficient" or "test-retest" correlation). Either
number of Axis I disorders, or the specific Axis I disorders
were significant predictors of HSCL-25 at T2 when HSCL-
25 scores at T1 were entered into the equation. The other
predictors remained significant even when controlling for
baseline mental distress.
Discussion
The course of mental distress
The level of mental distress at follow-up was as high as
that at admission (2.01 ± 0.63 vs. 2.08 ± 0.61, respec-
tively, P = 0.219), and far above the level in the general
population. In a population study from Norway [31]
using the HSCL-25, the mean score was 1.33 (SD:SE =
0.004). The stability of mental distress over six years is
supported by some of the literature [13-16], and shows
that, on a group level among substance-dependent sub-
jects who seek treatment, the level of mental distress will
not go away by itself or with time. The level of mental dis-
tress in our sample was also high at both baseline and fol-
low-up, even when compared with other follow-up
studies of SUD patients [17,39]. We also found more Axis
I disorders at baseline than did other studies, like ours,
that used CIDI [4,40,41].
In the different subgroups, the most important finding
was that mental distress substantially decreased in the
"abstinent" group, especially among women, whereas it
remained stable and high in the "relapse" group. The
mean score at follow up among the "abstinent" women
(1.41 ± 0.37) was similar to the level of mental distress in
the general population study [31], where the mean level
for women was 1.37 (SD:SE = 0.006). Among "abstinent"
men (1.69 ± 0.66) mental distress was higher than for
men in the population study1.28 (SD:SE = 0.006). There-
fore, our group of abstinent women seems to have
obtained a distribution of mental distress that is very sim-
ilar to that of women in the general population, whereas
the abstinent group of men still has a somewhat higher
level of distress than that of men in the general popula-
tion.
Our findings may also indicate that mental distress in
women is more strongly associated with ongoing addic-
tive behaviour than it is among men. In a 16-month fol-
low-up study, Tomasson and Vaglum found a significant
relationship between duration of sobriety and lower psy-
chiatric distress, but this association was less clear for
women [23]. In our multivariate analyses, sex was not an
independent predictor of the level of mental distress at T2.
In all, it is important to remember that all studies, includ-
ing our own, show that eliminating the addictive behav-
iour does not always lead to a clinically significant
reduction in mental distress. Consequently, Axis I and II
disorders, and not only the SUD, should be addressed in
treatment programmes.
Among single Axis I disorders, only patients with simple
phobias and PTSD had a significant decrease in mental
distress. In our study, as in others [42], simple phobias
were not as severe as many of the other Axis I disorders
and are therefore possibly easier to eradicate. The decrease
in mental distress we observed in patients with PTSD is in
contrast to a review of SUD patients with PTSD [43] that
reported poor outcomes on mental distress and that the
negative effect of a comorbid PTSD diagnosis was greater
than the effects of other comorbid psychiatric disorders.
However, the generalizability of the studies included in
that review can be discussed with regard to both sampling
(male SUD patients in VA treatment centres) and method-
ology (lack of structured clinical interview). When con-
trolling for baseline mental distress only a few of the
differences in table 2 and 3 remained significant, prima-
rily the variables with the greatest differences in HSCL-25
score at T2. Much of the impact of the various Axis I and
II disorders on HSCL-25 at T2 was due to the HSCL-25
level at index admission.
Predictors of mental distress at follow-up
The number of Axis I disorders was significant and inde-
pendently related to the level of mental distress when we
controlled for age, sex, Axis II disorders, and substance-
use variables at both T1 and T2. This is in accordance with
the results of several studies with shorter follow-up inter-
val [20-24]. Only patients with ≥ 4 Axis I disorders at base-
line reported a significant decrease in their levels of
mental distress from baseline to follow up. Nevertheless,BMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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the level of mental distress was still very high in this sub-
group. Grella et al. [6], Melberg et al. [39], and Liskow et
al. [44] also found the greatest reduction in psychiatric
severity in those groups who were highest at baseline. This
may be due to the fact that patients seek help when their
mental distress is at a maximum.
In the multivariate analyses, anxiety disorders (GAD,
SAD, sum of anxiety disorders) together with somatiza-
tion disorders were significant and independently related
to a high level of mental distress at follow-up. Haver and
Gjestad [45] also found phobic anxiety to be an important
predictor of outcome in female alcohol-dependent
patients, partly due to the influence phobic anxiety had
on depression. In general, anxiety disorders are more sta-
ble than affective disorders [46], and they should always
be the focus of therapeutic interventions among SUD
patients. Compared with the other Axis I disorders that
had a significant and independent impact on mental dis-
tress at follow-up, social anxiety disorder was a more
important predictor of mental distress. There is a high
degree of impairment associated with SAD and higher risk
of persistence compared with that of other anxiety disor-
ders [46,47]. Patients with SAD in our index sample expe-
rienced more comorbid mental disorders than did
patients without SAD [27], and most patients with SAD in
our sample exhibited generalized SAD, a subtype that
causes more impairment than the non-generalized type
[48].
No single affective disorder had an impact on the level of
mental distress at follow-up, but because the total number
of Axis I disorders had such an impact, affective disorders
may have made a more non-specific contribution. The lit-
erature concerning SUD patients with depression con-
firms our finding that psychiatric symptoms may improve
when sobriety occurs. Hatsukami and Pickens [49] and
Driessen et al. [50] also reported that the rate and severity
of depressive symptoms among sober alcohol-dependent
patients were similar to those of the general population.
However, those studies were short-term follow-up studies.
In a 10-year follow-up study of patients with major
depressive disorders with and without alcohol depend-
ence, there was a twofold greater likelihood of improve-
ment in the major depressive disorders in patients
without a current alcohol disorder compared with that of
patients with an active alcohol disorder [51]. In a five-year
follow-up study of alcohol-dependent patients with
major depression, remission of alcoholism strongly and
significantly increased the chances of remission of depres-
sion [52]. Hodgins et al. followed alcohol-dependent
patients for three years and found that among patients
with good drinking outcomes, 26% suffered depression
compared with 60% of those with poor drinking out-
comes [18].
In the multivariate analyses none of the Axis I disorders or
number of Axis I disorders was a predictor of mental dis-
tress at T2 when controlling for HSCL-25 at T1. Much of
the impact of Axis I disorders was due to shared variance
with HSCL-25. HSCL-25 is a dimensional measure of anx-
iety and depressive symptoms whereas diagnosing Axis I
disorders is a categorical way of measuring mostly anxiety
disorders and affective disorders, i.e. closely related phe-
nomena. Thus, there was a high correlation between Axis
I disorders and HSCL-25, not least between a tally of the
number of Axis I disorders and HSCL-25 scores (r = 0.61).
Both number of personality disorders and some specific
disorders, mostly of the anxious and dramatic types, were
independently related to a relatively poor outcome con-
cerning mental distress, when we also controlled for sex,
age, number of Axis I disorders, and substance use both at
baseline and at follow-up. Those with a personality disor-
der continued to have a high level of mental distress from
T1 to T2. The persistence of mental distress in patients
with many Axis II disorders is consistent with a recent
review showing that Axis II disorders are often associated
with poor outcomes for psychiatric problems among SUD
patients [25]. This underlines once more the importance
of considering the personality disorders of SUD patients.
When entering HSCL-25 at T1 into the analysis, the
number of PD's still remained a significant predictor of
mental distress at T2. This underscores the long-term
impact of personality disorders on mental distress.
Number of disorders may be a more robust measure than
each specific disorder. Among the specific Axis II disorders
only passive-aggressive still remained significant.
Our findings in this study demonstrate the importance of
anxiety disorders for the level of mental distress at the six-
year follow-up, whereas another study of the same follow-
up sample [53] has shown that major depression and ago-
raphobia are significant and independent predictors of a
harmful use of substances in the year prior to follow up.
Together, these findings underscore the need to offer sub-
stance-dependent patients treatment that focuses not only
on their substance abuse, but also on their anxiety, affec-
tive, and personality disorders.
On bivariate analysis, there was no significant difference
in the mental distress of alcohol-dependent and poly-sub-
stance-dependent patients. However, in the multivariate
analysis, the main substance of abuse (alcohol = 1)
became a significant predictor of a high level of mental
distress at T2 when we controlled for age or age at onset of
SUD. Alcohol-dependent patients were older than poly-
substance-dependent patients and they were older at the
onset of SUD. In patients with an onset of SUD before 18
years, there was a significantly higher level of mental dis-
tress at T2 among alcohol-dependent patients thanBMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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among poly-substance-dependent patients (2.39 ± 0.43
vs. 2.06 ± 0.43, respectively, P = 0.051). Even if poly-sub-
stance-dependent patients have more Axis I and II disor-
ders [2], the level of mental distress in purely alcohol-
dependent patients should not be underestimated.
The subgroup with an early age at onset of SUD had a sig-
nificantly higher level of mental distress at follow-up
(when we controlled for all other variables) compared
with that of the late-onset group. At baseline the EO group
were younger (33.1 vs. 42.9 years, P = < 0.001), more fre-
quently poly-substance dependent (72% vs. 21%, P = <
0.001), had more often only primary school (62% vs.
35%, P = 0.002) and more often any Axis I disorder (97%
vs. 84%, P = 0.016). The high level of mental distress in
the EO group is in accordance with the finding of Babor et
al., who reported higher average distress in type B alcohol-
ics (with early onset of alcoholism) than that in type A
alcoholics (with late-onset of alcoholism), in both one-
year and three-year follow-up studies [54]. It seems that
patients with an early onset of SUD are more seriously dis-
turbed and less integrated into society.
In contrast to the majority of studies, we did find a direct,
independent association between substance-use variables
at admission and the level of mental distress at follow-up
when we controlled for sex, age, Axis I and II variables,
and for substance use during the year preceding follow-
up. It is also important to note that, when we controlled
for substance use at follow-up (and in the previous year),
both Axis I and II disorders and baseline SUD variables
remained independent and significant predictors of men-
tal distress at follow-up. This shows that the impact of Axis
I and II variables on the course of mental distress does not
totally act through the substance use in the follow-up
period, but that each of the variables had an independent
impact on the mental distress outcome. This implies that
one cannot expect total improvement in the other, poten-
tially very disturbing, mental disorders, by limiting treat-
ment to the addictive behaviour. The substance abuse
field should involve the diagnosis and treatment of Axis I
and II disorders as disorders independent of SUD.
Limitations
A major strength of this study is that the sample is a con-
secutive sample, with heterogeneity of clients with regard
to the number of facilities involved, the numbers of inpa-
tients and outpatients, and the main substance of abuse.
We have also used both a well-established structured
interview (CIDI) and self-report instruments (MCMI,
HSCL-25). The relatively long follow-up period (75
months) is also a strength, minimizing the "baseline
effect" [22].
The representativeness of the sample is always a problem
in clinical studies. The follow-up sample comprised only
20% of the patients that fulfilled the original inclusion cri-
teria (137/690); 48% of those were included at index
admission (137/287); and 54% of those from the index
admission sample that were still living six years later (137/
254). Our baseline sample was only somewhat skewed
towards having fewer young poly-substance-dependent
subjects compared with a national sample [26], but age
has not been an important variable in this part of our
study. In this follow-up study, we found no significant dif-
ferences between dropouts and participants, either at
baseline or in the follow-up sample, in terms of any of the
central substance use or psychopathology variables. Nev-
ertheless, a proportion of patients with high mental dis-
tress may have found it difficult to participate in the
follow-up study, and we may have underestimated the
level of mental distress at follow-up.
Although we assessed the most relevant substance use and
psychopathology variables at baseline and at follow-up,
other factors concerning substance use, such as important
life events, treatment received, and social stability factors,
may have influenced the outcome during the follow-up
period. Furthermore, we were unable to examine either
the stability of substance use or temporal changes in sub-
stance use. To evaluate mental distress at follow-up, a new
CIDI interview would have been ideal, but due to a lack of
resources, we had to use well-established self-report
instruments with well-demonstrated sensitivity and spe-
cificity in measuring mental distress and in identifying
harmful use of substances.
Another weakness of this study is that we did not have any
confirmatory information regarding either the patients'
use of substances nor mental health variables, but had to
rely on the patients' willingness to report the truth. How-
ever, many recent studies have supported the validity of
self-reports of substance use [55].
In all, although the external validity of the level of mental
distress after six years may be unclear, we believe that the
final sample we have followed up is well suited to identi-
fying important predictors of mental distress among sub-
stance-abusing patients.
Conclusion
In conclusion, this study shows that the level of mental
distress among treatment-seeking SUD patients, on a
group level, remained high after six years, but was signifi-
cantly lower among those who had been abstainers, espe-
cially among women abstainers. Both the number of and
the type of specific lifetime Axis I disorders (social anxiety
disorder, GAD, and somatisation disorder), the number
of and specific types of Axis II disorders (anxious andBMC Psychiatry 2007, 7:29 http://www.biomedcentral.com/1471-244X/7/29
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impulsive personality disorders), and the severity of SUD
at the index admission were all independent predictors of
a high level of mental distress at follow-up, even when we
controlled for substance use at follow-up. These findings
underscore the importance of the parallel diagnosis and
treatment of both SUD and non-SUD Axis I and Axis II
disorders in the same programme.
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